Patients with acute rubella infection
Precharacterisation of low-and high-avidity serum panels with in-house rubella virus IgG avidity assay
The EUROIMMUN Anti-Rubella Virus ELISA (avidity) showed an excellent correlation with the in-house rubella virus IgG avidity assay.
The EUROIMMUN assay was statistically signifi cantly better (P < 0.01) than the commercial assays from Behring, Adaltis and Diesse.
The EUROIMMUN Anti-Rubella Virus ELISA (avidity) was the only test in this study to reliably identify acute rubella virus infections: the avidity index for all low-avidity sera was clearly below 40%. Comparison of in-house rubella virus IgG avidity assay with fi ve commercial rubella virus avidity assays using the precharacterised sera (low-avidity and high-avidity panels)
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